Literature DB >> 12853411

Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.

Fernando Lopes Gonçales1, Josiane Silveira Felix Pereira, Claudia Da Silva, Glaucimari Roberto Thomaz, Maria Helena Postal Pavan, Viviane Cristina Fais, Luis Alberto Magna, Neiva Sellan Lopes Gonçales.   

Abstract

With the use of PCR, we searched for hepatitis B virus (HBV) DNA in serum samples from 415 HBsAg-negative, anti-HBc-positive patients: 150 were blood donors, 106 had only hepatitis C virus (HCV) infection, and 159 had human immunodeficiency virus (HIV) infection (of which 88 were HCV positive and 71 were HCV negative). HBV DNA was detected in 4% of blood donors, 3.4% of HIV- and HCV-positive patients, and 24% of HCV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853411      PMCID: PMC164243          DOI: 10.1128/cdli.10.4.718-720.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

Review 1.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

Authors:  C Bréchot; V Thiers; D Kremsdorf; B Nalpas; S Pol; P Paterlini-Bréchot
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

2.  Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen.

Authors:  R P Perrillo; E M Brunt
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

3.  High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology.

Authors:  I Chemin; F Zoulim; P Merle; A Arkhis; M Chevallier; A Kay; L Cova; P Chevallier; B Mandrand; C Trépo
Journal:  J Hepatol       Date:  2001-03       Impact factor: 25.083

4.  Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Authors:  I Cacciola; T Pollicino; G Squadrito; G Cerenzia; M E Orlando; G Raimondo
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

5.  Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.

Authors:  Damien Jeantet; Isabelle Chemin; Bernard Mandrand; Fabien Zoulim; Christian Trepo; Alan Kay
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

6.  Serological pattern "anti-HBc alone": report on a workshop.

Authors:  P Grob; W Jilg; H Bornhak; G Gerken; W Gerlich; S Günther; G Hess; H Hüdig; A Kitchen; H Margolis; G Michel; C Trepo; H Will; A Zanetti; I Mushahwar
Journal:  J Med Virol       Date:  2000-12       Impact factor: 2.327

7.  Prevalence of markers of hepatitis B in the adult German population.

Authors:  W Jilg; B Hottenträger; K Weinberger; K Schlottmann; E Frick; A Holstege; J Schölmerich; K D Palitzsch
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

8.  Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.

Authors:  R Fukuda; N Ishimura; S Hamamoto; M Moritani; Y Uchida; S Ishihara; S Akagi; M Watanabe; Y Kinoshita
Journal:  J Med Virol       Date:  2001-03       Impact factor: 2.327

9.  Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique.

Authors:  S Kaneko; S M Feinstone; R H Miller
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

10.  Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

Authors:  W Jilg; E Sieger; R Zachoval; H Schätzl
Journal:  J Hepatol       Date:  1995-07       Impact factor: 25.083

View more
  5 in total

Review 1.  Prevalence of occult hepatitis B virus infection.

Authors:  Maria Luisa Gutiérrez-García; Conrado M Fernandez-Rodriguez; Jose Luis Lledo-Navarro; Ingrid Buhigas-Garcia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

2.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients.

Authors:  Ma Teresa Pérez-Rodríguez; Bernardo Sopeña; Manuel Crespo; Alberto Rivera; Teresa González del Blanco; Antonio Ocampo; César Martínez-Vázquez
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

3.  Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors.

Authors:  Raj Nath Makroo; Mohit Chowdhry; Aakanksha Bhatia; Minimol Antony
Journal:  Asian J Transfus Sci       Date:  2015 Jan-Jun

4.  Seroprevalence of Human Immunodeficiency Virus, Hepatitis B, Hepatitis C, Syphilis and Co-infections among Antenatal Women in a Tertiary Institution in South-East Nigeria.

Authors:  Lc Ikeako; Hu Ezegwui; Lo Ajah; Cc Dim; Tc Okeke
Journal:  Ann Med Health Sci Res       Date:  2014-09

5.  Seroprevalence of Human Immunodeficiency Virus, Hepatitis B, Hepatitis C, Syphilis, and Co-infections among Antenatal Women in a Tertiary Institution in South East, Nigeria.

Authors:  Lc Ikeako; Hu Ezegwui; Lo Ajah; Cc Dim; Tc Okeke
Journal:  Ann Med Health Sci Res       Date:  2014-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.